Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Component Te-100 Implants With Tylan 100 mg Implant is a Health Canada–registered veterinary drug (DIN 02366916) held by Elanco Canada Limited, containing Trenbolone Acetate. Health Canada lists its status as Marketed (status date 27 Feb 2019). Nexara Health has matched 3 registrations of Trenbolone Acetate across 1 other regulated market.

Health Canada registration

DIN02366916
Brand nameComponent Te-100 Implants With Tylan
Active ingredientTrenbolone Acetate
Strength100 mg
Dosage formImplant
RouteSubcutaneous
CompanyElanco Canada Limited
StatusMarketed — 27 Feb 2019
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Trenbolone Acetate registered in other markets

3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesTrenbolone acetateValdepharmPowderFDA NDC
United StatesTrenbolone AcetatePharmacia and Upjohn Company LLCPowderFDA NDC
United StatesTrenbolone AcetateLaurus Synthesis Pvt LtdPowderFDA NDC

See every manufacturer of Trenbolone Acetate worldwide →

Marketed Canadian products with the same active ingredient

DINProductCompanyStrengthForm
02407760Component Te-200 Implants With TylanElanco Canada Limited20 mgImplant

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Component Te-100 Implants With Tylan (DIN 02366916) marketed in Canada?

Yes. Health Canada lists DIN 02366916 as Marketed as of 27 Feb 2019.

Who holds the Canadian licence for this product?

Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.

Is Trenbolone Acetate registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02366916, status date 2019-02-27; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02366916, status date 2019-02-27; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02366916, status date 2019-02-27; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.